According to Immuneering's latest financial reports the company's current EPS (TTM) is -$3.27. In 2022 the company made an earnings per share (EPS) of -$3.25 a decrease over its 2021 EPS that were of -$2.86.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.16 | -2.8% |
2022 | -$3.25 | 13.92% |
2021 | -$2.86 | 33.64% |
2020 | -$2.14 |